EUCTR2007-007546-36-CZ进行中（未招募）不适用
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy in Diabetic Patients with Renal Insufficiency
Institute for Clinical and Experimental Medicine0 个研究点开始时间: 2008年1月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Scheduled procedure with exposure to radiographic contrast
- •Age = 18 years
- •Diabetes mellitus defined by use of antidiabetic medication
- •Stable renal insufficiency with P-creatinine = 100 µmol/l
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Emergency procedure
- •P-creatinine = 500 µmol/l or dialysis treatment
- •Acute renal failure with P-creatinine change of = 50 µmol/l / 24 hours
- •Fluid overload with pulmonary edema
- •Uncontrolled hypertension (systolic BP = 180 and/or diastolic BP = 110 mmHg) or hemodynamic instability (systolic BP = 90 and/or diastolic BP = 50 mmHg)
- •Allergy to or use of radiographic contrast within 2 days of the study
- •Use of other treatment to prevent contrast-induced nephropathy
- •Multiple myeloma
- •Planned use of other medical substance to prevent radiocontrast nephropathy
研究者
相似试验
进行中（未招募）
不适用
Sodium Bicarbonate for the prevention of Contrast Induced Nephropathy in patients undergoing CTPA - The Nephros StudyThe prevention of Contrast Induced Nephropathy is under investigation.Contrast induced nephropathy (CIN) can occur after injecting radiographic iso osmolair contrast media. Patients with a renal impairment or a decreased renal function and aspecially in combination with diabetis mellitus are at risk for developing CIN.MedDRA version: 12.0Level: LLTClassification code 10037790Term: Radiocontrast nephropathyEUCTR2009-013547-11-NLeids Universitair Medisch Centrum
已完成
3 期
Sodium Bicarbonate for the prevention of contrast induced nephropathy in patients suspected with acute pulmonary embolism undergoing CTPAacute renale failure following contrastcontrastnephropathy1006447710029149NL-OMON38375eids Universitair Medisch Centrum140
招募中
不适用
Sodium Bicarbonate for the prevention of contrast induced nephropathy in patients suspected with acute pulmonary embolism undergoing CTPA.Contrast Induced Nephropathy (contrastnefropathie)CT-pulmonary angiography (CTPA)Sodium bicarbonate (natriumbicarbonaat)Prevention (preventie)NL-OMON25804ame: Judith KooimanAddress: Leiden University Medical Center, Albinusdreef 2, Postzone C4-70, 2333 ZA Leiden, The Netherlandsemail: j.kooiman@lumc.nltel: +31 (0)71-526.20.85264
招募中
4 期
Oral sodium bicarbonate to reduce contrast induced nephropathyCoronary artery diseaseRenal impairmentContrast induced nephropathyCardiovascular - Coronary heart diseaseRenal and Urogenital - Kidney diseaseDiabetes mellitusACTRN12608000205336Michael Mok100
已完成
4 期
Sodium Bicarbonate for kidney protection in patients undergoing liver transplantatioiver transplantationLiver transplantationAnaesthesiology - AnaestheticsSurgery - Other surgeryRenal and Urogenital - Other renal and urogenital disordersAcute Kidney InjuryACTRN12611001290987Austin Hospital60